2.86 USD
↗ 0.13 (4.76%)PRE MARKET (AS OF 04:14 AM EDT)
Chemomab Therapeutics Ltd. American Depositary Share
CMMBNASDAQ • USD
Market: OPEN
CMMB is currently priced at $2.86. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Sep 2, 2026.
Open?$2.86
High?$2.86
Low?$2.86
Prev. Close?$2.73
Volume?124
Avg. Volume?90.7K
VWAP?$2.86
Rel. Volume?0.00x
Bid / Ask
Bid?$2.72 × 100
Ask?$2.81 × 100
Spread?$0.09
Midpoint?$2.77
Valuation & Ratios
Market Cap?20.0M
Shares Out?7.2M
P/E Ratio?N/A
P/B Ratio?0.72
EPS?-$4.27
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Employees
12
Market Cap
20.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-03-17
Address
KIRYAT ATIDIM, BUILDING 7
TEL AVIV, L3 6158002
Phone: 972-77-331-0156
TEL AVIV, L3 6158002
Phone: 972-77-331-0156
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?56
Piotroski F-Score?0/9Weak
Altman Z-Score?-9.86Distress
Confidence?49%Low
Short InterestLow
Short Interest?113.2K
Days to Cover?1.9
Avg Daily Volume58.9K
Settlement Date2026-08-14
Financial Health
Current Ratio?4.83Strong
Quick Ratio?4.83Strong
Cash Ratio?2.97Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.72CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.0CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-111.9%WEAK▾
S&P3
ROA?-89.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-23900000
Enterprise Value?$-760488
Fundamentals ratios updated end of day